Bright Minds Biosciences's total assets for Q1 2025 were C$58.40M, an increase of 856.63% from the previous quarter. DRUG total liabilities were C$571.59K for the fiscal quarter, a 0.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.